Showing results (191-200 of 1,688) with videos related to
Sort By:
Pageof 169
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Genomic medicine frontier in human solid tumors: prospects and challengesRodrigo Dienstmann, Jordi Rodon, Jordi Barretina, et al.Future Oncology (London, England)|April 21, 2012
Panitumumab: a summary of clinical development in colorectal cancer and future directionsGuillem Argiles, Rodrigo Dienstmann, Elena Elez, et al.Clinical Colorectal Cancer|July 7, 2011
Development of molecular biomarkers in individualized treatment of colorectal cancerLeticia De Mattos-Arruda, Rodrigo Dienstmann, Josep TaberneroFuture Oncology (London, England)|November 25, 2011
Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancerLeticia De Mattos-Arruda, David Olmos, Josep TaberneroExpert Opinion on Emerging Drugs|September 1, 2016
Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancerIgnacio Matos, Elena Elez, Jaume Capdevila, et al.The Oncologist|December 3, 2011
Toxicity as a biomarker of efficacy of molecular targeted therapies: focus on EGFR and VEGF inhibiting anticancer drugsRodrigo Dienstmann, Irene Braña, Jordi Rodon, et al.Molecular Cancer Therapeutics|April 22, 2014
Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitorsRodrigo Dienstmann, Jordi Rodon, Violeta Serra, et al.Critical Reviews in Oncology/Hematology|June 14, 2014
What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?Jaume Capdevila, Alfredo Carrato, Josep Tabernero, et al.Methods in Molecular Medicine|December 9, 2004
Application of donor lymphocytes expressing a suicide gene for early GVL induction and later control of GVH reactions after bone-marrow transplantationAttilio Bondanza, Fabio Ciceri, Chiara BoniniJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excisionMin Yi, Funda Meric-Bernstam, Henry M Kuerer, et al.Pageof 169